METHODS AND COMPOSITIONS FOR DETERMINING HEART FAILURE OR A RISK OF HEART FAILURE
    1.
    发明申请
    METHODS AND COMPOSITIONS FOR DETERMINING HEART FAILURE OR A RISK OF HEART FAILURE 审中-公开
    用于确定心脏衰竭或心脏衰竭风险的方法和组合

    公开(公告)号:WO2012160551A3

    公开(公告)日:2013-03-28

    申请号:PCT/IL2012000201

    申请日:2012-05-23

    CPC classification number: C12Q1/6883 C12Q2600/158 C12Q2600/178

    Abstract: The present invention is based in part on the discovery of a panel of miRs whose levels are increased or decreased in the circulation of chronic systolic HF patients. Accordingly, an extensive panel of miRs was screened in the sera of stable chronic systolic HF patients and the results were compared to an age, gender and ethnically matched control group.

    Abstract translation: 本发明部分基于在慢性收缩期HF患者的循环中水平升高或降低的一组miR的发现。 因此,在稳定的慢性收缩期HF患者的血清中筛选出广泛的miRs组,并将结果与​​年龄,性别和种族匹配的对照组进行比较。

    NUCLEIC ACIDS INVOLVED IN VIRAL INFECTION
    2.
    发明申请
    NUCLEIC ACIDS INVOLVED IN VIRAL INFECTION 审中-公开
    涉及病毒感染的核酸

    公开(公告)号:WO2009024834A3

    公开(公告)日:2011-12-29

    申请号:PCT/IB2007004718

    申请日:2007-12-05

    Abstract: Provided are isolated viral and human nucleic acids including microRNAs associated with different viral infection, including HSV1, HSV2, RSV, EBV, Influenza A, HIV, HPV, HIV, HBV, and Vaccinia viral infection. The disclosure further provides methods for detecting viral infection using the nucleic acids, and methods of inhibiting and treating viral infection using pharmaceutical composition comprising associated nucleic acids.

    Abstract translation: 提供了分离的病毒和人类核酸,包括与不同病毒感染相关的微RNA,包括HSV1,HSV2,RSV,EBV,甲型流感,HIV,HPV,HIV,HBV和痘苗病毒感染。 本公开进一步提供了使用核酸检测病毒感染的方法,以及使用包含相关核酸的药物组合物来抑制和治疗病毒感染的方法。

Patent Agency Ranking